| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/20/1994 | EP0606661A1 Octahydrophenanthrene derivatives and their use as NMDA-Antagonists |
| 07/20/1994 | EP0606658A1 Substituted N-aminoalkylmethansulphoamides as antispasmodic agents |
| 07/20/1994 | EP0606657A1 Ketorolac derivative having considerably less gastrointestinal irritation and ulceration |
| 07/20/1994 | EP0606599A1 Oral care compositions containing hop acids |
| 07/20/1994 | EP0606590A1 Pharmaceutical or cosmetic composition containing N-acylalcanolamines and N-acylphospho- or lysophospholipids |
| 07/20/1994 | EP0606506A1 Beta-lactamase resistant antibacterial composition |
| 07/20/1994 | EP0606457A1 Vaginal mucoadhesive gel, medicament containing it and its method of preparation |
| 07/20/1994 | EP0606421A1 Derivatives of imidazo 5,1-c] 1, 4]benzoxazin-1-one as 5 ht3 antagonists |
| 07/20/1994 | EP0606393A1 Topical ophthalmic compositions comprising 4-(3-substituted amino-2-hydroxypropoxy)-1,2,5-thiadiazoles and methods for their use |
| 07/20/1994 | EP0606386A1 Dermatological and/or cosmetological composition containing retinoids. |
| 07/20/1994 | EP0606382A1 1,8-benzonaphthyridine derivatives and antimicrobial compositions |
| 07/20/1994 | EP0606380A1 2-substituted quinolines for treating leishmanioses |
| 07/20/1994 | EP0606376A1 Method for genetically modifying bone marrow cells of primates, and useful cells therefor that produce recombinant retroviral vectors |
| 07/20/1994 | EP0606366A1 Substituted phenserines and phenylcarbamates of (-)-eseroline, (-)-n1-noreseroline, and (-)-n1-benzylnoreseroline; as specific inhibitors of acetylcholinesterase |
| 07/20/1994 | EP0606332A1 Method of producing starch decomposition products with a narrow molecular-weight distribution |
| 07/20/1994 | EP0606318A1 Vanadium compositions |
| 07/20/1994 | EP0606317A1 Saponin-antigen conjugates and the use thereof |
| 07/20/1994 | EP0606308A1 Fluoroalkylated amphiphilic ligands, their metallic complexes and their uses |
| 07/20/1994 | EP0606304A1 N-hydroxyquinazolinone and 2-n-hydroxythiourea benzoate compounds as biocides |
| 07/20/1994 | EP0606248A1 Heteroaryl amines as novel acetyl cholinesterase inhibitors |
| 07/20/1994 | EP0606197A1 Derivatives of aromatic benzoates as inhibitors of esterase-producing micro-organisms. |
| 07/20/1994 | EP0565579B1 2-imino 6-polyfluoralkyl 3-heterocyclylalkyl benzothiazoline derivatives, their preparation and drugs containing same |
| 07/20/1994 | EP0505379B1 Muscarinic receptor antagonists |
| 07/20/1994 | EP0417105B1 Topically applied gold organic complex |
| 07/20/1994 | EP0414806B1 High ratio active agent:lipid complex |
| 07/20/1994 | EP0380560B1 Use of tetracycline for the manufacture of a medicament for lowering the intraocular pressure |
| 07/20/1994 | CN1089656A Prepn. method and application of alpha-amylase inhibitor |
| 07/20/1994 | CN1089624A Carboxybinil polymer which shows newtonian viscosity |
| 07/20/1994 | CN1089617A Process for prepn. of sodium olean-phthalate |
| 07/20/1994 | CN1089614A Alpha-phosphonosulfonate squalene synthetase inhibitors and method |
| 07/20/1994 | CN1089613A Novel phosphonocarboxylate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism |
| 07/20/1994 | CN1089611A Optical active isoindolinone derivatives, their production and use |
| 07/20/1994 | CN1089608A Imidazopyridines |
| 07/20/1994 | CN1089607A Monohydrate of 5-(2-(4-(1,2 benzisothiazol-3-YL)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one hydrochloride |
| 07/20/1994 | CN1089606A Antiretroviral acyl compounds |
| 07/20/1994 | CN1089603A Novel pyridine-2-carboxylase and pyridine-N-oxide and preparation and pharmaceutical use of same |
| 07/20/1994 | CN1089599A Derivative of vitamin D system which is modified in 20-position, preparation of same and pharmaceutical made of same |
| 07/20/1994 | CN1089474A Nadh and Nadph as drugs for treating alzheimer's disease |
| 07/20/1994 | CN1089473A Compound henbane seed injection to artery or vein and prepn. method therefor |
| 07/20/1994 | CN1089472A Controlled release morphine preparation |
| 07/20/1994 | CN1089471A Stable extended release oral dosage composition |
| 07/20/1994 | CN1089469A Two-phase matrix for sustained release drug delivery |
| 07/20/1994 | CN1025500C Process for prepn. of heteroaryl 3-oxo-propanenitrile derivatives |
| 07/20/1994 | CN1025475C Controlled release rate eye-pill of chloromycetin and method for prepn. of same |
| 07/20/1994 | CA2113686A1 Liquefied gas formulation for testing the vitality of teeth |
| 07/20/1994 | CA2113658A1 Isolation and elucidation of cephalostatin 7, 8 and 9 |
| 07/20/1994 | CA2113657A1 Isolation and structure of hallistatin 2 |
| 07/20/1994 | CA2113655A1 Isolation and structure of hallistatin 1 |
| 07/20/1994 | CA2113580A1 Organic compounds |
| 07/20/1994 | CA2113513A1 Quinolone- und naphthyridonecarboxylic acid derivatives |
| 07/19/1994 | US5331014 Effect of N,N,N-trimethylsphingosine on protein kinase-C activity; melanoma cell growth in vitro; metastatic potential in vivo and human platelet aggregation |
| 07/19/1994 | US5331013 Method for the treatment of ulcerative proctitis and colitis |
| 07/19/1994 | US5331012 Topical pharmaceutical preparation for fever blisters and other viral infections and method of use |
| 07/19/1994 | US5331009 Pharmaceutical compositions for treating adrenoleukodystrophy |
| 07/19/1994 | US5331008 Thioester enantiomeric compounds and their therapeutic uses |
| 07/19/1994 | US5331007 Arylalkyl-amines and -amides having anticonvulsant and neuroprotective properties |
| 07/19/1994 | US5331005 Amidines derived from 3-aminoethyl indoles and process for the preparation thereof |
| 07/19/1994 | US5331003 Anticoccidial methods |
| 07/19/1994 | US5331002 5-aryl-4-alkyl-3H-1,2,4-triazole-3-thiones useful as memory enhancers |
| 07/19/1994 | US5331000 Antipyretic and analgesic methods and compositions containing optically pure R(-) ketoprofen |
| 07/19/1994 | US5330999 2,4-thiazolidinedione compounds |
| 07/19/1994 | US5330997 Treatment of diabetic complications |
| 07/19/1994 | US5330993 Immunosuppressive compounds |
| 07/19/1994 | US5330990 Substituted urea compounds and their preparation and use |
| 07/19/1994 | US5330987 Substituted pyridopyrimidinones and related heterocycles as angiotensin II antagonists |
| 07/19/1994 | US5330986 Analgesics |
| 07/19/1994 | US5330985 2-amino-N-[[4-(aminocarbonyl)pyrimidin-2-yl]amino]-alkyl]pyrimidine-4-carboxamide derivatives, their preparation and pharmaceutical compositions containing them |
| 07/19/1994 | US5330983 14-O-p-chlorobenzoylaconine and analgesic/anti-inflammatory agent containing the same |
| 07/19/1994 | US5330982 Pharmaceutical composition containing a 5-HT receptor antagonist and an H+ K+ Atpase inhibitor and a method of treating gastrointestingal disorders therewith |
| 07/19/1994 | US5330981 Arylalkyl esters of 4,5-dihydroxy-9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic acid having therapeutical activity |
| 07/19/1994 | US5330980 Medicament for the topical treatment of skin |
| 07/19/1994 | US5330979 Method of treating renal disorders with inositoltriphosphate |
| 07/19/1994 | US5330977 Di-N-acetyl lysoganglioside compositions |
| 07/19/1994 | US5330976 Antimycotic compositions of nikkomycin compounds and azole antimycotics |
| 07/19/1994 | US5330975 Bacterial toxin neutralizer |
| 07/19/1994 | US5330973 Lipopeptide derivatives |
| 07/19/1994 | US5330972 Method of impeding apoptosis of CD4 cells in persons infected with human immunodeficiency virus |
| 07/19/1994 | US5330762 Tandospiaine antidepressive therapy |
| 07/19/1994 | US5330760 Effervescent antacid |
| 07/19/1994 | US5330757 Method for the prevention and reversal of the extrinsic aging of the skin by transdermal application of selenamino acids and compositions therefore |
| 07/19/1994 | US5330755 Process for the production of an anti-diarrheic product based on carob |
| 07/19/1994 | US5330744 Method for increasing sensitivity to chemically induced terminal differentiation |
| 07/19/1994 | US5330689 Drug delivery |
| 07/19/1994 | CA2007260C Effervescent analgesic antacid composition having reduced sodium content (ms-1569-cip-11) |
| 07/19/1994 | CA1330806C Vitamin d_ derivatives having a substituent at 2-position |
| 07/19/1994 | CA1330802C Process for the preparation of n,n'-bis-(alkoxyalkyl)-pyridine-2,4-dicarboxamides |
| 07/19/1994 | CA1330798C Benzo- and thieno-3,4-dihydro-pyridine derivatives |
| 07/19/1994 | CA1330796C Pharmaceutical compositions comprising 15-ketoprostaglandin e or f compounds for inducing uterine contractions |
| 07/19/1994 | CA1330795C Antiparasitic agents |
| 07/19/1994 | CA1330794C Anti-viral compounds, dosage forms and methods |
| 07/19/1994 | CA1330793C Platinum pharmaceuticals |
| 07/19/1994 | CA1330791C Oral delivery system |
| 07/19/1994 | CA1330759C Method for the treatment of gastro intestinal disorders |
| 07/16/1994 | CA2113491A1 Salts of 4-pyrimidinone derivatives, their preparation and their therapeutic application |
| 07/16/1994 | CA2113490A1 9h-imidazo[1,2-a]benzimidazole-3-acetamide derivatives, their preparation and their therapeutic application |
| 07/16/1994 | CA2112786A1 Substituted dialkylthio ethers |
| 07/16/1994 | CA2111138A1 Octahydrophenanthrene derivatives |
| 07/15/1994 | WO1994015921A1 Imidazoline derivative, production thereof, and blood pressure retentive |
| 07/15/1994 | CA2381458A1 Process for constructing a cdna library and a novel polypeptide and dna coding the same |
| 07/14/1994 | CA2113226A1 Ketorolac derivatives with considerably reduced gastro-intestinal irritation and ulceration |